XBiotech Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
XBiotech Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • XBiotech Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $379K, a 58.5% decline year-over-year.
  • XBiotech Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.4M, a 36.5% decline year-over-year.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.26M, a 35.6% decline from 2022.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.06M, a 13.4% increase from 2021.
  • XBiotech Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.46M, a 64.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.4M $379K -$535K -58.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.94M $381K -$324K -46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.26M $688K -$350K -33.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $3.61M $955K -$173K -15.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.79M $914K -$534K -36.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $4.32M $705K -$743K -51.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $5.06M $1.04M -$316K -23.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $5.38M $1.13M -$5K -0.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.38M $1.45M +$408K +39.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $4.98M $1.45M +$512K +54.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $4.46M $1.35M -$1.44M -51.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $5.9M $1.13M -$2.02M -64.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $7.93M $1.04M -$2.14M -67.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $10.1M $936K -$2.52M -72.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $12.6M $2.79M +$1.29M +85.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $11.3M $3.16M +$2.36M +296% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $8.93M $3.18M +$2.69M +553% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.24M $3.46M +$2.89M +506% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $3.36M $1.51M +$1.03M +218% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 $2.33M $797K +$358K +81.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.97M $486K -$151K -23.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.12M $570K +$460K +418% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.66M $474K +$65K +15.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 $1.6M $439K -$6K -1.35% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.6M $637K -$261K -29.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.86M $110K -$614K -84.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.48M $409K -$1.12M -73.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $3.6M $445K -$681K -60.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $4.28M $898K -$200K -18.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $4.48M $724K -$1.09M -60.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $5.57M $1.53M +$480K +45.6% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-03-15
Q3 2016 $5.09M $1.13M +$240K +27.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $4.85M $1.1M -$149K -11.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $5M $1.82M +$595K +48.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $4.41M $1.05M -$996K -48.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $5.4M $886K -$1.64M -64.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $7.04M $1.25M +$641K +106% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $6.4M $1.22M -$620K -33.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $7.02M $2.05M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $2.52M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $606K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $1.84M Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.